BrightBid Group AB (publ)
Research BrightBid Group AB (publ) (PERP-B) on Bullrun: valuation model: 63.8% undervalued, market cap SEK 30.72M, P/E 6.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPERP-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Valuation signal63.8% undervalued
- Market capSEK 30.72M
- P/E6.3
- Financial periodQ4 2025
- RevenueSEK 5.16M
- Net income-SEK 2.86M
- Free cash flow-SEK 3.05M
- Gross margin52.9%
Valuation Snapshot
Bullrun's latest valuation model marks BrightBid Group AB (publ) as 63.8% undervalued; latest market cap is SEK 30.72M; P/E is 6.3.
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations.
Frequently asked questions
Is BrightBid Group AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks BrightBid Group AB (publ) as 63.8% undervalued.
What is BrightBid Group AB (publ)'s market cap?
BrightBid Group AB (publ)'s market capitalization is SEK 30.72M.
What is BrightBid Group AB (publ)'s P/E ratio?
BrightBid Group AB (publ)'s price-to-earnings (P/E) ratio is 6.3.
What does BrightBid Group AB (publ) do?
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances;